TY - JOUR
T1 - SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: A nationwide prospective cohort study from the Italian Society of Neonatology
AU - Pugni, Lorenza
AU - Crippa, Beatrice Letizia
AU - Raimondi, Francesco
AU - Vento, Giovanni
AU - Mangili, Giovanna
AU - Coscia, Alessandra
AU - Artieri, Giacomo
AU - Ronchi, Andrea
AU - Ventura, Maria Luisa
AU - Lago, Paola
AU - Pietrasanta, Carlo
AU - Crimi, Riccardo
AU - Crimi, Rocco
AU - Bonfante, Giuseppina
AU - Perrone, Serafina
AU - Boncompagni, Alessandra
AU - Solinas, Agostina
AU - Agosti, Massimo
AU - Poggi, Chiara
AU - Falcone, Alessandra
AU - Pagliotta, Claudia
AU - Gianotti, Daniela
AU - Gottardi, Genny
AU - Paviotti, Giulia
AU - Allodi, Alessandra
AU - Maffei, Gianfranco
AU - Proto, Alice
AU - Travierso, Antonella
AU - Salomè, Serena
AU - Costa, Simonetta
AU - Ferrari, Stefania
AU - Peila, Chiara
AU - Sinelli, Mariateresa
AU - Fanelli, Federica
AU - Giordano, Lucia
AU - Saruggia, Martina
AU - Capasso, Letizia
AU - Spada, Elena
AU - Gizzi, Camilla
AU - Orfeo, Luigi
AU - Mosca, Fabio
PY - 2024
Y1 - 2024
N2 - Objectives: To describe how SARS-CoV-2 infection at the time of delivery affected maternal and neonatal outcomes across four major waves of the COVID-19 pandemic in Italy. Methods: This is a large, prospective, nationwide cohort study collecting maternal and neonatal data in case of maternal peripartum SARS-CoV-2 infection between February 2020 and March 2022. Data were stratified across the four observed pandemic waves. Results: Among 5201 COVID-19-positive mothers, the risk of being symptomatic at delivery was significantly higher in the first and third waves (20.8-20.8%) than in the second and fourth (13.2-12.2%). Among their 5284 neonates, the risk of prematurity (gestational age < 37 weeks) was significantly higher in the first and third waves (15.6-12.5%). The risk of intrauterine transmission was always very low, while the risk of postnatal transmission during rooming-in was higher and peaked at 4.5% during the fourth wave. A total of 80% of positive neonates were asymptomatic. Conclusion: The risk of adverse maternal and neonatal outcomes was significantly higher during the first and third waves, dominated by unsequenced variants and the Delta variant, respectively. Postnatal transmission accounted for most neonatal infections and was more frequent during the Omicron period. However, the paucity of symptoms in infected neonates should lead us not to separate the dyad.
AB - Objectives: To describe how SARS-CoV-2 infection at the time of delivery affected maternal and neonatal outcomes across four major waves of the COVID-19 pandemic in Italy. Methods: This is a large, prospective, nationwide cohort study collecting maternal and neonatal data in case of maternal peripartum SARS-CoV-2 infection between February 2020 and March 2022. Data were stratified across the four observed pandemic waves. Results: Among 5201 COVID-19-positive mothers, the risk of being symptomatic at delivery was significantly higher in the first and third waves (20.8-20.8%) than in the second and fourth (13.2-12.2%). Among their 5284 neonates, the risk of prematurity (gestational age < 37 weeks) was significantly higher in the first and third waves (15.6-12.5%). The risk of intrauterine transmission was always very low, while the risk of postnatal transmission during rooming-in was higher and peaked at 4.5% during the fourth wave. A total of 80% of positive neonates were asymptomatic. Conclusion: The risk of adverse maternal and neonatal outcomes was significantly higher during the first and third waves, dominated by unsequenced variants and the Delta variant, respectively. Postnatal transmission accounted for most neonatal infections and was more frequent during the Omicron period. However, the paucity of symptoms in infected neonates should lead us not to separate the dyad.
KW - Neonate
KW - Newborn
KW - Pandemic
KW - Neonate
KW - Newborn
KW - Pandemic
UR - http://hdl.handle.net/10807/304681
U2 - 10.1016/j.ijid.2023.12.011
DO - 10.1016/j.ijid.2023.12.011
M3 - Article
SN - 1201-9712
VL - 140
SP - 17
EP - 24
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -